Follow
Pablo Laborda Martínez
Pablo Laborda Martínez
Postdoctoral researcher
Verified email at biosustain.dtu.dk
Title
Cited by
Cited by
Year
Antimicrobial resistance: A multifaceted problem with multipronged solutions
T Gil‐Gil, P Laborda, F Sanz‐García, S Hernando‐Amado, P Blanco, ...
Microbiologyopen 8 (11), e945, 2019
502019
Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin
P Laborda, F Sanz-García, S Hernando-Amado, JL Martínez
Current Opinion in Microbiology 64, 125-132, 2021
452021
Coming from the wild: multidrug resistant opportunistic pathogens presenting a primary, not human-linked, environmental habitat
F Sanz-García, T Gil-Gil, P Laborda, LE Ochoa-Sánchez, JL Martínez, ...
International Journal of Molecular Sciences 22 (15), 8080, 2021
422021
Wildlife and antibiotic resistance
P Laborda, F Sanz-García, LE Ochoa-Sánchez, T Gil-Gil, ...
Frontiers in cellular and infection microbiology 12, 873989, 2022
392022
Novel Inducers of the Expression of Multidrug Efflux Pumps That Trigger Pseudomonas aeruginosa Transient Antibiotic Resistance
P Laborda, M Alcalde-Rico, P Blanco, JL Martínez, S Hernando-Amado
Antimicrobial Agents and Chemotherapy 63 (11), 10.1128/aac. 01095-19, 2019
242019
Mutational background influences P. aeruginosa ciprofloxacin resistance evolution but preserves collateral sensitivity robustness
S Hernando-Amado, P Laborda, JR Valverde, JL Martínez
Proceedings of the National Academy of Sciences 119 (15), e2109370119, 2022
212022
Convergent phenotypic evolution towards fosfomycin collateral sensitivity of Pseudomonas aeruginosa antibiotic‐resistant mutants
P Laborda, JL Martínez, S Hernando‐Amado
Microbial Biotechnology 15 (2), 613-629, 2022
202022
Antibacterial mechanism of Biochanin A and its efficacy for the control of Xanthomonas axonopodis pv. glycines in soybean
KX Hu, XC Shi, D Xu, P Laborda, GC Wu, FQ Liu, P Laborda, SY Wang
Pest Management Science 77 (4), 1668-1673, 2021
202021
Biocontrol ability of phenazine-producing strains for the management of fungal plant pathogens: A review
SY Wang, XC Shi, X Chen, P Laborda, YY Zhao, FQ Liu, P Laborda
Biological control 155, 104548, 2021
192021
Rapid decline of ceftazidime resistance in antibiotic-free and sublethal environments is contingent on genetic background
S Hernando-Amado, P Laborda, JR Valverde, JL Martínez
Molecular Biology and Evolution 39 (3), msac049, 2022
162022
Discovery of inhibitors of Pseudomonas aeruginosa virulence through the search for natural‐like compounds with a dual role as inducers and substrates of efflux …
P Laborda, M Alcalde‐Rico, A Chini, JL Martínez, S Hernando‐Amado
Environmental Microbiology 23 (12), 7396-7411, 2021
162021
Antibiotic Resistance in Pseudomonas
P Laborda, S Hernando-Amado, JL Martínez, F Sanz-García
Pseudomonas aeruginosa: Biology, Pathogenesis and Control Strategies, 117-143, 2022
152022
Translating eco-evolutionary biology into therapy to tackle antibiotic resistance
F Sanz-García, T Gil-Gil, P Laborda, P Blanco, LE Ochoa-Sánchez, ...
Nature Reviews Microbiology 21 (10), 671-685, 2023
142023
Tackling antibiotic resistance by inducing transient and robust collateral sensitivity
S Hernando-Amado, P Laborda, JL Martínez
Nature Communications 14 (1), 1723, 2023
142023
A perfusion chamber for monitoring transepithelial NaCl transport in an in vitro model of the renal tubule
J Yeste, L Martínez‐Gimeno, X Illa, P Laborda, A Guimerà, ...
Biotechnology and Bioengineering 115 (6), 1604-1613, 2018
112018
Evolution of habitat-dependent antibiotic resistance in Pseudomonas aeruginosa
P Laborda, JL Martínez, S Hernando-Amado
Microbiology Spectrum 10 (4), e00247-22, 2022
102022
Mode of action and efficacy of quinolinic acid for the control of Ceratocystis fimbriata on sweet potato
Y Chen, YD Zhou, P Laborda, HL Wang, R Wang, X Chen, FQ Liu, ...
Pest Management Science 77 (10), 4564-4571, 2021
102021
Rapid phenotypic convergence towards collateral sensitivity in clinical isolates of Pseudomonas aeruginosa presenting different genomic backgrounds
S Hernando-Amado, C López-Causapé, P Laborda, F Sanz-García, ...
Microbiology spectrum 11 (1), e02276-22, 2023
72023
Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?
T Gil-Gil, P Laborda, LE Ochoa-Sánchez, JL Martínez, ...
Expert Opinion on Drug Discovery 18 (6), 671-686, 2023
62023
Antimicrobial resistance: A multifaceted problem with multipronged solutions. Microbiologyopen. 2019; 8 (11): e945
T Gil-Gil, P Laborda, F Sanz-García, S Hernando-Amado, P Blanco, ...
4
The system can't perform the operation now. Try again later.
Articles 1–20